BIALX | CNPFX | BIALX / CNPFX | |
Total Expense Ratio | 0.91 | 0.84 | 108% |
Annual Report Gross Expense Ratio | 0.91 | 0.84 | 108% |
Fund Existence | 10 years | 23 years | - |
Gain YTD | 12.374 | 15.881 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 250 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.47B | 159B | 2% |
Annual Yield % from dividends | 0.33 | 0.64 | 51% |
Returns for 1 year | 14.53 | 15.24 | 95% |
Returns for 3 years | 65.19 | 50.25 | 130% |
Returns for 5 years | 68.43 | 37.07 | 185% |
Returns for 10 years | 220.65 | 110.42 | 200% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.44 | 0.17 | +0.88% |
Saratoga Health & Biotechnology A | |||
BHSRX | 57.77 | 0.28 | +0.49% |
BlackRock Health Sciences Opps R | |||
GOFCX | 27.58 | 0.09 | +0.33% |
Victory Pioneer Select Mid Cap Growth C | |||
RPMFX | 16.55 | 0.02 | +0.12% |
Reinhart Genesis PMV Advisor | |||
ETLNX | 15.56 | 0.01 | +0.06% |
Eventide Large Cap Focus N |